USE OF A BENZODIAZEPINE DERIVATIVE AND METHOD OF TREATMENT OF TRAUMATIC BRAIN INJURY

Present invention aims to protect a new use of JM-20, a benzodiazepine derivative, in the treatment of and recovery from traumatic brain injury (TBI) and its related symptoms. Additionally, it provides a method of treatment for TBI-induced brain damage.

Saved in:
Bibliographic Details
Main Authors FREIRE ROYES, Luiz Fernando, PADRON YAQUIS, Alejandro Saul, CASSOL, Gustavo, VIEIRA FURTADO, Andrezza Bond, DUARTE HARTMANN, Diane, FARINA GONÇALVES, Debora, ALVES COURTES, Aline, NÚÑEZ FIGUEREDO, Yanier, ANTUNES SOARES, Félix Alexandre, MONDELO RODRIGUEZ, Abel
Format Patent
LanguageEnglish
Published 24.11.2022
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:Present invention aims to protect a new use of JM-20, a benzodiazepine derivative, in the treatment of and recovery from traumatic brain injury (TBI) and its related symptoms. Additionally, it provides a method of treatment for TBI-induced brain damage.
Bibliography:Application Number: US202017788813